ArticlePhysiological research2022

Rho-kinase inhibition ameliorates non-alcoholic fatty liver disease in type 2 diabetic rats.

H A Elkattawy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.